€52.00
-1.14%
Compare
Clinica Baviera S.A vs Pangaea OncologyClinica Baviera S.A vs EuroEspes S.AClinica Baviera S.A vs Grifols, S.AClinica Baviera S.A vs LaboratoriosClinica Baviera S.A vs Almirall S.AClinica Baviera S.A vs IBEX 35 | MarketI

TL;DR: Financial Overview - Revenue, Profits & Key Metrics

Latest Quarterly: Dec 2025

Income Metrics

Revenue 81.7M
Operating Income 18.9M 23.07%
Net Income 14.6M 17.91%

Balance Sheet Metrics

Total Assets 247.5M
Total Liabilities 136.6M
Shareholders Equity 111.0M
Debt to Equity 1.23

Cash Flow Metrics

Operating Cash Flow 19.5M
Free Cash Flow 7.4M

Revenue & Profitability Trend

Quarter Income Flow i

Annual Income Flow i

Clinica Baviera S.A Income Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Revenue i 301.8M 262.6M 224.9M 198.4M 172.7M
Cost of Goods Sold i 34.0M 30.6M 27.1M 25.5M 21.5M
Gross Profit i 267.8M 232.1M 197.8M 172.9M 151.2M
Gross Margin % i 88.7% 88.4% 88.0% 87.1% 87.6%
Operating Expenses
Research & Development i - - - - -
Selling, General & Administrative i 38.7M 35.5M 26.2M 28.2M 23.2M
Other Operating Expenses i 25.9M 19.3M 17.5M 15.0M 11.7M
Total Operating Expenses i 64.6M 54.8M 43.6M 43.2M 34.9M
Operating Income i 60.6M 55.6M 50.0M 42.1M 39.5M
Operating Margin % i 20.1% 21.2% 22.2% 21.2% 22.8%
Non-Operating Items
Interest Income i 1.5M 296.5K 151.3K 67.2K 3.2K
Interest Expense i 2.3M 1.2M 571.7K 418.8K 458.3K
Other Non-Operating Income - - - - -
Pre-tax Income i 60.1M 56.0M 49.7M 40.7M 38.9M
Income Tax i 17.2M 14.9M 12.9M 10.5M 11.0M
Effective Tax Rate % i 28.6% 26.5% 26.0% 25.9% 28.2%
Net Income i 42.9M 41.1M 36.7M 30.1M 27.9M
Net Margin % i 14.2% 15.7% 16.3% 15.2% 16.2%
Key Metrics
EBITDA i 86.0M 76.8M 67.2M 57.0M 53.5M
EPS (Basic) i €2.58 €2.47 €2.21 €1.81 €1.68
EPS (Diluted) i €2.58 €2.47 €2.21 €1.81 €1.68
Basic Shares Outstanding i 16013795 16001440 16302654 16303008 16303008
Diluted Shares Outstanding i 16013795 16001440 16302654 16303008 16303008

Income Statement Trend

Clinica Baviera S.A Balance Sheet From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Assets
Current Assets
Cash & Equivalents i 5.6M 10.1M 8.3M 19.2M 9.8M
Short-term Investments i 44.8M 28.4M 42.9M 19.8M 22.5M
Accounts Receivable i 4.6M 4.0M 3.0M 2.8M 3.4M
Inventory i 3.3M 3.3M 2.5M 2.2M 1.9M
Other Current Assets 857.5K 1.5M 1.0M 584.4K 270.4K
Total Current Assets i 59.3M 47.7M 57.7M 44.6M 37.9M
Non-Current Assets
Property, Plant & Equipment i 142.9M 129.5M 114.1M 104.8M 95.1M
Goodwill i 69.1M 65.3M 32.0M 29.7M 30.2M
Intangible Assets i 11.1M 8.7M 2.7M 461.1K 997.8K
Long-term Investments - - - - -
Other Non-Current Assets -374.5K - - - -
Total Non-Current Assets i 188.2M 164.0M 120.9M 105.5M 95.9M
Total Assets i 247.5M 211.7M 178.6M 150.1M 133.8M
Liabilities
Current Liabilities
Accounts Payable i 21.4M 17.2M 15.5M 15.6M 13.0M
Short-term Debt i 13.1M 11.3M 10.8M 9.9M 11.7M
Current Portion of Long-term Debt - - - - -
Other Current Liabilities 8.0M -1 - - 644.8K
Total Current Liabilities i 61.5M 50.4M 45.3M 41.0M 35.9M
Non-Current Liabilities
Long-term Debt i 57.5M 52.1M 36.7M 38.0M 39.9M
Deferred Tax Liabilities i 1.6M 914.0K 513.8K 260.1K 292.4K
Other Non-Current Liabilities - - - - 644.8K
Total Non-Current Liabilities i 75.1M 62.9M 41.1M 40.7M 42.5M
Total Liabilities i 136.6M 113.3M 86.4M 81.7M 78.4M
Equity
Common Stock i 1.6M 1.6M 1.6M 1.6M 1.6M
Retained Earnings i 42.1M 40.2M 36.0M 29.5M 27.4M
Treasury Stock i 8.4M 9.1M 109.9K 93.7K 75.9K
Other Equity - - - - -
Total Shareholders Equity i 111.0M 98.4M 92.3M 68.4M 55.4M
Key Metrics
Total Debt i 70.6M 63.5M 47.4M 47.9M 51.6M
Working Capital i -2.1M -2.7M 12.5M 3.6M 2.1M

Balance Sheet Composition

Clinica Baviera S.A Cash Flow Statement From 2021 to 2025

Metric 2025 2024 2023 2022 2021
Operating Activities
Net Income i 60.1M 56.0M 49.7M 40.7M 38.9M
Depreciation & Amortization i - - - - -
Stock-Based Compensation i - - - - -
Working Capital Changes i 240.8K -29.9K -745.4K -52.2K -1.2M
Operating Cash Flow i 61.6M 57.2M 49.3M 41.4M 38.2M
Investing Activities
Capital Expenditures i -30.0M -26.5M -22.7M -14.0M -10.6M
Acquisitions i -918.5K -11.1M - 0 -50.0K
Investment Purchases i -35.9M -14.2M -40.5M -24.5M -10.5M
Investment Sales i 20.3M 30.6M 18.7M 25.9M 4.0M
Investing Cash Flow i -46.5M -21.2M -44.5M -12.6M -17.1M
Financing Activities
Share Repurchases i -2.4M -10.2M -706.5K -617.4K -491.4K
Dividends Paid i -26.4M -25.9M -13.6M -17.2M -17.3M
Debt Issuance i 3.0M 7.2M - 0 79.8K
Debt Repayment i -2.3M -2.5M -2.0M -6.1M -5.8M
Financing Cash Flow i -24.5M -25.5M -15.6M -23.3M -23.0M
Free Cash Flow i 46.8M 36.0M 35.1M 39.3M 36.3M
Net Change in Cash i -9.4M 10.5M -10.8M 5.5M -1.9M

Cash Flow Trend

Clinica Baviera S.A Key Financial Ratios

Valuation Ratios

P/E Ratio (TTM) 19.77
Forward P/E 29.55
Price to Book 7.57
Price to Sales 2.73
PEG Ratio 29.55

Profitability Ratios

Profit Margin 13.80%
Operating Margin 22.22%
Return on Equity 41.02%
Return on Assets 16.48%

Financial Health

Current Ratio 0.96
Debt to Equity 62.33
Beta 0.71

Per Share Data

EPS (TTM) €2.63
Book Value per Share €6.87
Revenue per Share €19.04

Peer Financial Comparison

Company Market Cap P/E Ratio P/B Ratio ROE Profit Margin Debt/Equity
CBAV 833.0M 19.77 7.57 41.02% 13.80% 62.33
Pangaea Oncology 61.8M -50.34 3.07 -29.97% -37.18% 23.04
EuroEspes S.A 6.2M - - -12.57% 88.31% 0.70
Grifols, S.A 6.1B 15.58 1.19 6.17% 5.34% 126.83
Laboratorios 4.3B 36.12 6.59 22.33% 18.89% 18.04
Almirall S.A 2.8B 58.64 1.86 3.10% 4.14% 23.30
Nippun Rana

Nippun Rana

Chasing the market trend!

Hi, I’m Nippun, a tech enthusiast from Haryana, India. I have been coding since 2010 and using my coding skills in the share market since 2020. I have been coding scripts in Pinescript that work on Tradingview app/web. I love learning about new technology and applying it to solve real-world problems. Coding and share-market are my passions, and I enjoy finding and fixing bugs in code. I aim to share my skill set and experience that can positively impact society. Feel free to connect with me, an...

Financial data is updated regularly. All figures are in the company's reporting currency.